Adiponectin gene single-nucleotide polymorphisms and treatment response to obesity

Journal of Endocrinological Investigation

Volumn 32, Issue 5, 2009, Pages 395-400

  Tsuzaki, K ^a   Kotani, K ^a   Nagai, N ^b   Saiga, K ^a   Sano, Y ^a   Hamada, T ^c   Moritani, T ^d   Yoshimura, M ^e   Egawa, K ^e   Horikawa, C ^e   Kitagawa, Y ^e   Kiso, Y ^e   Sakane, N ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY OF HEALTH AND SPORT SCIENCES   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e Suntory Wellness Limited Research Center   (Japan)

Author keywords

Adipocytokine; Caloric restriction; Diet intervention; Polymorphism

Indexed keywords

ADIPONECTIN; DNA; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CALORIC RESTRICTION; CLINICAL ARTICLE; DNA DETERMINATION; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE; GENE EXPRESSION REGULATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; JAPAN; LIFESTYLE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SINGLE NUCLEOTIDE POLYMORPHISM; SNP 11377 GENE; SNP 276 GENE; SNP 45 GENE; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; WAIST CIRCUMFERENCE;

EID: 70350342288     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346474     Document Type: Article

References (34)

1. Japan Society for the Study of Obesity. New definition and diagnostic standard of obesity. Himan Kenkyu 2000, 6: 18-28.
2. The Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity. New criteria for "obesity disease" in Japan. Circ J 2002, 66: 987-992
3. Ministry of Health, Labor, and Welfare. The National health and nutrition survey in Japan, 2003. Tokyo. Ministry of Health, Labour, and Welfare 2005, 149-184
4. Hill JO, Wyatt H. Outpatient management of obesity: a primary care perspective. Obes Res 2002, 10 (Suppl): 124S-30S. (Pubitemid 41132566)
5. Berkel LA, Poston WS, Reeves RS, Foreyt JP. Behavioral interventions for obesity. J Am Diet Assoc 2005, 105: S35-43.
6. Klein S. Outcome success in obesity. Obes Res 2001, 9 (Suppl): 354S-8S.
7. Davidson MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA 1999, 281: 235-242 (Pubitemid 29058112)
8. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005, 365: 1415-1428
9. Yoshida T, Sakane N, Umekawa T, Sakai M, Takahashi T, Kondo M. Mutation of beta 3-adrenergic-receptor gene and response to treatment of obesity. Lancet 1995, 346: 1433-1434
10. Sakane N, Yoshida T, Umekawa T, Kogure A, Takakura Y, Kondo M. Effects of Trp64Arg mutation in the beta 3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients. Diabetes Care 1997, 20: 1887-1890 (Pubitemid 27522901)
11. Kotani K, Sakane N, Saiga K, et al. The angiotensin II type 2 receptor gene polymorphism and body mass index in healthy Japanese women. Ann Clin Biochem 2007, 44: 83-85 (Pubitemid 46168807)
12. Kotani K, Saiga K, Kurozawa Y, Sakane N, Tsuzaki K, Hamada T. Adiponectin I164T gene polymorphism and the obesity-related effects on the Japanese female population. Clin Chim Acta 2007, 384: 182-183 (Pubitemid 47247420)
13. Schere PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270: 26746-26749
14. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996, 271: 10697-10703 (Pubitemid 26145805)
15. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996, 221: 286-289 (Pubitemid 26136463)
16. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 1996, 120: 803-812 (Pubitemid 26385421)
17. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257: 79-83. (Pubitemid 29299050)
18. Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol 2001, 86: 3815-3819 (Pubitemid 32755982)
19. Maeda N, Takahashi M, FunahashivT, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001, 50: 2094-2099 (Pubitemid 33643677)
20. Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001, 98: 2005-2010 (Pubitemid 32165613)
21. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001, 7: 947-953 (Pubitemid 32756433)
22. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7: 941-946 (Pubitemid 32756432)
23. Vasseur F, Leprêtre F, Lacquemant C, Froguel P. The genetics of adiponectin. Curr Diab Rep 2003, 3: 151-158
24. Menzaghi C, Ercolino T, Di Paola R, at al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002, 51: 2306-2312
25. Stumvoll M, Tschritter O, Fritsche A, et al. Association of the T-G polymorphism in adiponectin (exon2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 2002, 51: 37-41. (Pubitemid 34517977)
26. Hara K, Boutin P, Mori Y, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002, 51: 536-540 (Pubitemid 34764814)
27. Takahashi M, Arita Y, Yamagata K, et al. Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 2000, 24: 861-868 (Pubitemid 30449921)
28. Schäffler A, Barth N, Palitzsch KD, Drobnik W, Schölmerich J, Schmitz G. Mutation analysis of the human adipocyte-specific apM-1 gene. Eur J Clin Invest 2000, 30: 879-887 (Pubitemid 30799979)
29. Shin MJ, Jang Y, Koh SJ, et al. The association of SNP276G>T at adiponectin gene with circulating adiponectin and insulin resistance in response to mild weight loss. Int J Obes 2006, 30: 1702-1708 (Pubitemid 44863400)
30. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 1993, 92: 141-146 (Pubitemid 23208989)
31. Jang Y, Lee JH, Chae JS, et al. Association of the 276G→T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans. Am J Clin Nutr 2005, 82: 760-767 (Pubitemid 43779688)
32. Mousavinasab F, Tähtinen T, Jokelainen J, et al. Common polymorphism (single-nucleotide polymorphism SNP+45 and SNP+276) of the adiponectin gene regulate serum adiponectin concentrations and blood pressure in young Finnish men. Mol Genet Metab 2006, 87: 147-151 (Pubitemid 43199871)
33. Stenvinkel P, Marchlewska A, Pecoits-Filho R, et al. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 2004, 65: 274-281 (Pubitemid 38037514)
34. Hoefle G, Muendlein A, Saely CH, et al. The -11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men. Thromb Haemost 2007, 97: 451-457 (Pubitemid 46437808)